表紙
市場調查報告書

果酸換膚的全球市場:2020年∼2024年

Global Chemical Peel Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 496047
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
果酸換膚的全球市場:2020年∼2024年 Global Chemical Peel Market 2020-2024
出版日期: 2020年04月15日內容資訊: 英文 120 Pages
簡介

全球果酸換膚市場在2020年∼2024年的預測期間內,預計將以7%的年複合成長率增長,達到6,278萬美元的規模。市場成長的主要因素是對微創及非侵入性治療需求的增加,消費者美容意識的提升,及醫療費的增加。特別是微創及非侵入性的治療的需求提升,有望進一步促進市場增長。

本報告提供全球果酸換膚市場相關調查分析,提供市場規模及成長率,市場趨勢,推動市場要素,課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

摘要整理

市場形勢

市場規模

  • 市場定義
  • 市場區隔分析
  • 2019年的市場規模
  • 市場預測:從2019年到2024年的預測

波特的五力分析

各終端用戶市場區隔

  • 市場區隔
  • 各終端用戶比較:市場規模·預測(2019年∼2024年)
  • 醫院及健康福利設施
  • 皮膚科診所
  • 各終端用戶市場機會

客戶形勢

  • 概要

各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模·預測(2019年∼2024年)
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區
  • 主要國家
  • 地區的市場機會

成長要素,課題,及趨勢

  • 市場成長要素
  • 交易量的成長要素-需求主導型成長
  • 交易量的成長要素-供給主導型成長
  • 交易量的成長要素-外部要素
  • 交易量的成長要素-需求轉移到鄰近市場
  • 價格上升要素-通貨膨脹
  • 價格成長要素-從低價格單位轉變到高價格單位
  • 市場課題
  • 市場趨勢

業者情勢

  • 概要
  • 形勢的創新

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Allergan Plc
  • Bausch Health Companies Inc.
  • Colgate-Palmolive Co.
  • Image International Manufacturing LLC
  • Johson & Johnson
  • LOreal SA
  • Merz Pharma GmbH & Co.KGaA
  • PIERRE FABRE DERMO-COSMETIQUE USA INC.
  • Teoxane SA
  • Topix Pharmaceuticals Inc.

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR41348

Technavio has been monitoring the chemical peel market and it is poised to grow by $ 62.78 mn during 2020-2024 progressing at a CAGR of 7% during the forecast period. Our reports on chemical peel market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising demand for minimally invasive and non-invasive procedures, increase in beauty consciousness among consumers, and rise in healthcare spending. In addition, rising demand for minimally invasive and non-invasive procedures is anticipated to boost the growth of the market as well.

The chemical peel market analysis includes end-user segments and geographic landscapes

Technavio's ‘ chemical peel market ’ is segmented as below:

By End-user

  • Hospitals and recreation centers
  • Dermatology clinics

By Geographic Landscapes

  • APAC
  • Europe
  • North America
  • ROW

This study identifies the rise in medical tourism as one of the prime reasons driving the chemical peel market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our chemical peel market covers the following areas:

  • Chemical peel market sizing
  • Chemical peel market forecast
  • Chemical peel market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading chemical peel market vendors that include Allergan Plc, Bausch Health Companies Inc., Colgate-Palmolive Co., Image International Manufacturing LLC, Johson & Johnson, LO real SA, Merz Pharma GmbH & Co.KGaA, PIERRE FABRE DERMO COSMETIQUE USA INC., Teoxane SA, and Topix Pharmaceuticals Inc.. Also, the chemical peel market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user

  • Market segments
  • Comparison by End user
  • Hospitals and recreation centers - Market size and forecast 2019-2024
  • Dermatology clinics - Market size and forecast 2019-2024
  • Market opportunity by End user

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Allergan Plc
  • Bausch Health Companies Inc.
  • Colgate-Palmolive Co.
  • Image International Manufacturing LLC
  • Johson & Johnson
  • LOreal SA
  • Merz Pharma GmbH & Co.KGaA
  • PIERRE FABRE DERMO-COSMETIQUE USA INC.
  • Teoxane SA
  • Topix Pharmaceuticals Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibits

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 5
  • 5.Key Finding 6
  • 6.Key Finding 7
  • 7.Key Finding 8
  • 8.Market in focus
  • 9.Parent market
  • 10.Market characteristics
  • 11.Offerings of vendors included in the market definition
  • 12.Market segments
  • 13.Global - Market size and forecast 2019 - 2024 ($ million)
  • 14.Global market: Year-over-year growth 2019 - 2024 (%)
  • 15.Five forces analysis 2019 & 2024
  • 16.Bargaining power of buyers
  • 17.Bargaining power of suppliers
  • 18.Threat of new entrants
  • 19.Threat of substitutes
  • 20.Threat of rivalry
  • 21.Market condition - Five forces 2019
  • 22.End user placement - Market share 2019-2024 (%)
  • 23.Comparison by End user
  • 24.Hospitals and recreation centers - Market size and forecast 2019-2024 ($ million)
  • 25.Hospitals and recreation centers - Year-over-year growth 2019-2024 (%)
  • 26.Dermatology clinics - Market size and forecast 2019-2024 ($ million)
  • 27.Dermatology clinics - Year-over-year growth 2019-2024 (%)
  • 28. Market opportunity by End user
  • 29.Customer landscape
  • 30.Market share by geography 2019-2024 (%)
  • 31.Geographic comparison
  • 32.North America - Market size and forecast 2019-2024 ($ million)
  • 33.North America - Year-over-year growth 2019-2024 (%)
  • 34.Europe - Market size and forecast 2019-2024 ($ million)
  • 35.Europe - Year-over-year growth 2019-2024 (%)
  • 36.APAC - Market size and forecast 2019-2024 ($ million)
  • 37.APAC - Year-over-year growth 2019-2024 (%)
  • 38.ROW - Market size and forecast 2019-2024 ($ million)
  • 39.ROW - Year-over-year growth 2019-2024 (%)
  • 40.Key leading countries
  • 41.Market opportunity by geography ($ million)
  • 42.Impact of drivers and challenges
  • 43.Vendor landscape
  • 44.Landscape disruption
  • 45.Industry risks
  • 46.Vendors covered
  • 47.Market positioning of vendors
  • 48.Allergan Plc - Overview
  • 49.Allergan Plc - Business segments
  • 50.Allergan Plc - Key offerings
  • 51.Allergan Plc - Key customers
  • 52.Allergan Plc - Segment focus
  • 53.Bausch Health Companies Inc. - Overview
  • 54.Bausch Health Companies Inc. - Business segments
  • 55.Bausch Health Companies Inc. - Key offerings
  • 56.Bausch Health Companies Inc. - Key customers
  • 57.Bausch Health Companies Inc. - Segment focus
  • 58.Colgate-Palmolive Co. - Overview
  • 59.Colgate-Palmolive Co. - Business segments
  • 60.Colgate-Palmolive Co. - Key offerings
  • 61.Colgate-Palmolive Co. - Key customers
  • 62.Colgate-Palmolive Co. - Segment focus
  • 63.Image International Manufacturing LLC - Overview
  • 64.Image International Manufacturing LLC - Product and service
  • 65.Image International Manufacturing LLC - Key offerings
  • 66.Image International Manufacturing LLC - Key customers
  • 67.Image International Manufacturing LLC - Segment focus
  • 68.Johson & Johnson - Overview
  • 69.Johson & Johnson - Business segments
  • 70.Johson & Johnson - Key offerings
  • 71.Johson & Johnson - Key customers
  • 72.Johson & Johnson - Segment focus
  • 73.LOreal SA - Overview
  • 74.LOreal SA - Business segments
  • 75.LOreal SA - Key offerings
  • 76.LOreal SA - Key customers
  • 77.LOreal SA - Segment focus
  • 78.Merz Pharma GmbH & Co.KGaA - Overview
  • 79.Merz Pharma GmbH & Co.KGaA - Product and service
  • 80.Merz Pharma GmbH & Co.KGaA - Key offerings
  • 81.Merz Pharma GmbH & Co.KGaA - Key customers
  • 82.Merz Pharma GmbH & Co.KGaA - Segment focus
  • 83.PIERRE FABRE DERMO-COSMETIQUE USA INC. - Overview
  • 84.PIERRE FABRE DERMO-COSMETIQUE USA INC. - Business segments
  • 85.PIERRE FABRE DERMO-COSMETIQUE USA INC. - Key offerings
  • 86.PIERRE FABRE DERMO-COSMETIQUE USA INC. - Key customers
  • 87.PIERRE FABRE DERMO-COSMETIQUE USA INC. - Segment focus
  • 88.Teoxane SA - Overview
  • 89.Teoxane SA - Business segments
  • 90.Teoxane SA - Key offerings
  • 91.Teoxane SA - Key customers
  • 92.Teoxane SA - Segment focus
  • 93.Topix Pharmaceuticals Inc. - Overview
  • 94.Topix Pharmaceuticals Inc. - Product and service
  • 95.Topix Pharmaceuticals Inc. - Key offerings
  • 96.Topix Pharmaceuticals Inc. - Key customers
  • 97.Topix Pharmaceuticals Inc. - Segment focus
  • 98.Currency conversion rates for US$
  • 99.Research Methodology
  • 100.Validation techniques employed for market sizing
  • 101.Information sources
  • 102.List of abbreviations